Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
clinical trials
inclisiran
life sciences
national blog main
new york
new york blog main
3
×
new york top stories
regeneron pharmaceuticals
alnylam pharmaceuticals
boston top stories
cholesterol
national top stories
pcsk9 inhibitors
praluent
repatha
the medicines co.
alirocumab
biotech
data
drugs
evercore isi
evolocumab
heart attack
joseph swartz
ldl
mark timney
medicines co.
mt sinai hospital
pcsk9
peter wijngaard
prashant vaishnava
rna interference
san francisco blog main
san francisco top stories
sanofi
stroke
svb leerink
umer raffat
What
cholesterol
drug
3
×
lowering
3
×
medco
medicines
3
×
twice
aces
alnylam
announced
based
big
bringing
ceo
clears
closer
data
evidence
fda
filing
flexible
heart
inched
inclisiran
key
lasting
long
looms
market
meant
medicine
morning
nasdaq
new
open
partner
passed
pharmaceuticals
phase
positive
preps
Language
unset
Current search:
drug
×
medicines
×
" new york blog main "
×
lowering
×
@xconomy.com
5 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms